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Abstract
Background: Methionine sulfoxide reduction is an important protein repair pathway that protects
against oxidative stress, controls protein function and has a role in regulation of aging. There are
two enzymes that reduce stereospecifically oxidized methionine residues: MsrA (methionine-S-
sulfoxide reductase) and MsrB (methionine-R-sulfoxide reductase). In many organisms, these
enzymes are targeted to various cellular compartments. In mammals, a single MsrA gene is known,
however, its product is present in cytosol, nucleus, and mitochondria. In contrast, three mammalian
MsrB genes have been identified whose products are located in different cellular compartments.
Results:  In the present study, we identified and characterized alternatively spliced forms of
mammalian MsrA. In addition to the previously known variant containing an N-terminal
mitochondrial signal peptide and distributed between mitochondria and cytosol, a second mouse
and human form was detected in silico. This form, MsrA(S), was generated using an alternative first
exon. MsrA(S) was enzymatically active and was present in cytosol and nucleus in transfected cells,
but occurred below detection limits in tested mouse tissues. The third alternative form lacked the
active site and could not be functional. In addition, we found that mitochondrial and cytosolic forms
of both MsrA and MsrB in Drosophila could be generated by alternative first exon splicing.
Conclusion:  Our data suggest conservation of alternative splicing to regulate subcellular
distribution of methionine sulfoxide reductases.
Background
The sulfur atom of methionine residues is susceptible to
oxidation by reactive oxygen species. Oxidation of
methionines may affect protein structure and function
and has been implicated in various processes, such as oxi-
dative stress, accelerated aging, and neurodegenerative
diseases (reviewed in [1-6]). This oxidation generates a
diastereomeric mixture of methionine-S-sulfoxide and
methionine-R-sulfoxide. In contrast to irreversible protein
oxidation, such as carbonylation, methionine sulfoxide
can be reversibly reduced back to methionine by repair
enzymes, methionine sulfoxide reductases. There are two
known classes of these enzymes: MsrA (methionine-S-sul-
foxide reductase) and MsrB (methionine-R-sulfoxide
reductase). Although the catalytic mechanisms for MsrA
and MsrB are similar, these enzymes have different folds.
Most organisms from bacteria to humans encode MsrA
and MsrB genes in their genomes, however, some hyper-
thermophiles lack MsrA, MsrB, or both genes [7]. MsrA
and MsrB genes in several bacterial species are clustered
with each other and appear to form an operon. In addi-
Published: 16 March 2006
BMC Molecular Biology2006, 7:11 doi:10.1186/1471-2199-7-11
Received: 27 October 2005
Accepted: 16 March 2006
This article is available from: http://www.biomedcentral.com/1471-2199/7/11
© 2006Kim and Gladyshev; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Molecular Biology 2006, 7:11 http://www.biomedcentral.com/1471-2199/7/11
Page 2 of 6
(page number not for citation purposes)
tion, MsrA and MsrB proteins are often linked to each
other via direct domain fusion [7,8]. Single MsrA and
MsrB genes are present in yeast (e.g., Saccharomyces cerevi-
siae) and many other species (e.g., Caenorhabditis elegans
and Drosophila melanogaster) [7]. On the other hand, mul-
tiple genes of MsrA and MsrB have been found in mem-
bers of the plant kingdom, Arabidopsis thaliana [9,10] and
Chlamydomonas reinhardtii [11].
Human and mouse genomes contain one MsrA and three
MsrB genes [12,13]. The three mammalian MsrB products
are located in different cellular compartments [13]. MsrB1
(also known as selenoprotein R or selenoprotein X) is a
cytosolic and nuclear protein. MsrB2 (also known as CBS-
1) is targeted to mitochondria. Human MsrB3 gives rise to
two forms generated by alternative first exon splicing,
which are targeted to the endoplasmic reticulum (ER) and
Splice variants of mouse and human MsrA Figure 1
Splice variants of mouse and human MsrA. (A) Schematic illustration of genomic structures of alternatively spliced MsrA 
forms in humans and mice. Translation initiation sites are indicated by arrows. Exons are shown by boxes and are numbered. 
The number of residues in each of the human and mouse forms is indicated on the right. (B) Alignment of mouse and human 
mitochondrial MsrAs (the a form in A) and MsrA(S)s (the b form in A). The mitochondrial signal peptide is indicated in italics. 
The catalytic cysteine in the GCFWG sequence and two cysteine residues in the last exon are highlighted. The arrow indicates 
the last amino acid residue of exon 1.BMC Molecular Biology 2006, 7:11 http://www.biomedcentral.com/1471-2199/7/11
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mitochondria [13], whereas there is no evidence for alter-
native first exon splicing in the mouse MsrB3 gene [14].
Although only a single MsrA gene is found in mammals
[15,16], the corresponding protein is localized in both
cytosol and mitochondria [17]. Recently, we reported that
the mouse MsrA containing the N-terminal mitochondrial
signal peptide is targeted to cytosol, nucleus, and mito-
chondria [18].
Alternative splicing is viewed as a major mechanism
responsible for multiplicity of protein forms in higher
eukaryotes [19]. Herein, we have found and characterized
a new splice form of MsrA in mouse and human. We also
report on alternative splicing of MsrA and MsrB genes in
insects. Our data are consistent with the idea that alterna-
tive splicing is a conserved mechanism to regulate subcel-
lular distribution of methionine sulfoxide reductases in
mammals and other animals.
Results and discussion
Alternative splicing variants of human and mouse MsrA
As indicated in the Background, only a single MsrA gene is
present in human, mouse, and rat genomes. The 374-kb
human and 317-kb mouse MsrA genes consist of 6 exons,
which generate a previously known form of the enzyme.
This MsrA form contains an N-terminal mitochondrial
signal peptide (known as the mitochondrial MsrA form
and shown as the a form in Figure 1A, [GenBank: mouse,
NM_026322; human, NM_012331]). However, its sub-
cellular location is complex. In addition to mitochondria,
this protein is localized in cytosol and nucleus [18]. To
identify whether additional MsrA forms are present in
humans and mice, non-redundant and EST sequence
databases were searched using the known MsrA sequences
and the identified cDNAs were mapped on the genomic
sequences. Several alternatively spliced variants were
detected in both humans and mice. The most relevant
alternative spliced form was generated by alternative first
exon splicing (the b form in Figure 1A, [GenBank: mouse,
AK018338; human, AY690665]). It was mostly found in
brain ESTs, especially in early developmental stages (e.g.,
GenBank: F06683, H08256, R55838). This alternative
variant of mouse MsrA had an ORF of 191 residues (192
residues in humans), of which residues 5–191 corre-
sponded to residues 47–233 of the mitochondrial MsrA
form (Figure 1B). This form was designated as MsrA(S).
Additional alternative forms were also detected, but these
were likely enzymatically inactive. For example, an alter-
native form devoid of exon 3 was identified (the c form in
Figure 1A, [GenBank: mouse, BC014738; human,
CK819754]). However, this form lacked the active site
and it was not detected (based on its lower molecular
weight) in several mouse tissues tested and in mouse
fibroblast NIH 3T3 cells by western blot analyses (data
not shown). An additional alternative form has also been
detected, in which exon 6, the last exon, was replaced with
a segment of an unknown gene [GenBank: CD 365491].
This form shared the first exon with the mitochondrial
MsrA form, but it is likely catalytically inactive due to lack
of the last exon which contains two cysteine residues crit-
ical for catalysis. Other detected forms contained just
some of the MsrA exons.
MsrA(S) is enzymatically active and localized in cytosol 
and nucleus
We prepared a recombinant MsrA(S) form and character-
ized its catalytic activity. In parallel, we measured the
activity of the mitochondrial MsrA form for comparison.
The specific activity of MsrA(S) was 90 ± 7 nmol/min/mg
protein, which is 3-fold lower than that of the mitochon-
drial MsrA (260 ± 9 nmol/min/mg protein). The Km value
of MsrA(S) was 1.4 ± 0.3 mM, which is 4-fold higher than
that of the mitochondrial MsrA (0.37 ± 0.1 mM). To char-
acterize subcellular localization of MsrA(S) in mamma-
Subcellular localization of the MsrA(S) form Figure 2
Subcellular localization of the MsrA(S) form. (A) The 
MsrA(S) expression construct (pMsrA(S)ΔGFP) was trans-
fected into monkey kidney CV-1 cells. Transfected cells were 
stained with anti-MsrA antibodies followed by secondary 
anti-rabbit Cy5-conjugated antibodies. A set of two images is 
shown: left panel, immunofluorescence; right panel, phase 
contrast. (B) Green fluorescence images of CV-1 cells 
expressing GFP-fused MsrA(S) (left) and control proteins 
(pEGFP vector, right).BMC Molecular Biology 2006, 7:11 http://www.biomedcentral.com/1471-2199/7/11
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lian cells, we generated an expression construct
containing a full-length MsrA(S). The construct,
pMsrA(S)ΔGFP, was transfected into CV-1 cells, and
MsrA(S) location was determined by immunofluores-
cence using polyclonal MsrA antibodies. As shown in Fig-
ure 2, the protein was located in cytosol and nucleus. The
presence of MsrA(S) in these compartments was also con-
firmed by transfecting cells with a GFP-fusion construct,
pMsrA(S)-GFP.
Previously, we demonstrated that MsrA derived from the
protein form containing the mitochondrial signal peptide
is localized in cytosol and nucleus as well as in mitochon-
dria and proposed that the subcellular localization of
MsrA is controlled on a post-translational level [18]. To
test whether MsrA(S) can be detected in mouse tissues, we
carried out western blot analyses. Based on size compari-
son with bacterially-expressed His-tagged mitochondrial
MsrA and MsrA(S) that served as internal controls, we did
not detect the MsrA(S) form in any of the mouse tissues
tested (brain, kidney, and liver) (Figure 3). However, the
MsrA with the higher molecular weight (derived from the
form containing the mitochondrial signal peptide) was
easily detected in cytosol and mitochondria of these tis-
sues. As described previously [18], the cytosolic form was
slightly smaller than the form found in mitochondria, but
both of them were larger than the recombinant MsrA(S).
It is likely that the expression level of MsrA(S) is too low
to be detected or this form occurs in tissues not tested in
the current study. However, this form is clearly detectable
in EST databases in various organisms. In addition, a
recent review by Hansel et al. [12] stated that an alterna-
tive form of MsrA mRNA was detected by RT-PCR in
human HEK 293 embryonic kidney cells.
Alternative splicing forms of MsrA and MsrB in drosophila
Single MsrA and MsrB genes were identified by BLAST
searches in D. melanogaster. Known MsrA [GenBank:
AF541958] and MsrB [GenBank: AY070627] proteins are
thought to be represented by cytosolic forms [20]. We
searched for possible additional forms of these proteins in
EST and cDNA sequence databases and identified an alter-
native splicing variant of MsrA [GenBank: AI064299] and
MsrB [GenBank: NM_169368]. These forms were gener-
ated by alternative first exon splicing. They contained a
predicted mitochondrial signal peptide at the N-terminus
(Figure 4B) and were predicted to be mitochondrial pro-
teins. The genomic structure consisting of 4 exons and the
alternative splicing pattern of MsrA were similar to those
of MsrB (Figure 4A). However, as shown in deduced
amino acid sequences (Figure 4B), the translation initia-
tion codon of the cytosolic MsrB was located in exon 2.
We suggest that the two alternatively spliced forms of D.
melanogaster MsrA and MsrB repair oxidized methionine
residues in the cytosol and mitochondria, which are the
locations that correspond to the occurrences of mamma-
lian MsrA and MsrB in these compartments. We also ana-
lyzed additional insect sequences and found that the
alternative  D. melanogaster forms are conserved in D.
yakuba and D. pseudoobscura. In addition, the predicted
cytosolic and mitochondrial forms of MsrA were repre-
sented by Glossina EST sequences. Although further stud-
ies on the expression levels of MsrA(S) and occurrence of
this protein form in various mouse tissues require more
sensitive assays that are currently not available (and the in
vivo proof of the occurrence of multiple MsrA forms in
fruit flies is also needed), it seems remarkable that the
same mechanism is used to regulate subcellular distribu-
tion of MsrA in such different organisms as fruit flies and
mammals, and that in each case, cytosolic and mitochon-
drial forms are synthesized.
Conclusion
This study shows that in some animals alternative splicing
is a common mechanism to regulate subcellular distribu-
tion of methionine sulfoxide reductases, allowing target-
ing the system for repair of oxidized methionine residues
to different compartments.
Methods
Preparation of recombinant alternatively spliced form of 
mouse MsrA
To generate a C-terminal His-tagged MsrA(S) (an alterna-
tive form of MsrA), PCR was performed with primers ET-
SF (5'-CGCCATATGTCTAAAGCCAAACACCATGT-
Western blot analysis of MsrA forms Figure 3
Western blot analysis of MsrA forms. Cytosolic and 
mitochondrial fractions from adult mouse brain, kidney, and 
liver [18] were used. Equal amounts (30 μg) of proteins were 
loaded on SDS-PAGE. Lanes 1 and 2, purified recombinant 
His-tagged mitochondrial MsrA and His-tagged MsrA(S); 
lanes 3 and 4, brain cytosolic and mitochondrial fractions; 
lanes 5 and 6, kidney cytosolic and mitochondrial fractions; 
lanes 7 and 8, liver cytosolic and mitochondrial fractions.BMC Molecular Biology 2006, 7:11 http://www.biomedcentral.com/1471-2199/7/11
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CAGTGG-3') and ET-C (5'-ACACCTCGAGTTTTTTAAT-
GGCCATCGGGC-3') using pET-MsrA(L)-His which
encodes a C-terminal His-tagged mitochondrial MsrA
[18]. The amplified fragment was cloned into the NdeI/
XhoI sites of pET21b, resulting in pET-MsrA(S). The mito-
chondrial MsrA and MsrA(S) proteins were expressed in E.
coli BL21(DE3) cells, purified using TALON metal affinity
resin (Clontech) and analyzed for purity by SDS-PAGE.
Protein concentration was determined by the Bradford
method using bovine serum albumin as a standard.
Determination of MsrA activity and Km
MsrA activity was assayed using dabsylated L-methionine-
S-sulfoxide as a substrate. A typical reaction mixture (100
μl) for reduction of dabsyl-methionine-S-sulfoxide to
dabsyl-Met contained 50 mM sodium phosphate (pH
7.5), 50 mM NaCl, 20 mM DTT, 200 μM substrate, and 1–
2 μg of purified proteins. The reaction was carried out at
37°C for 30 min, and stopped by adding 200 μl of ace-
tonitrile. The reaction product, dabsyl-Met, was analyzed
by HPLC as described previously [20]. For determination
of Km, 50–800 μM substrate was used. The Km values were
determined using Lineweaver-Burk plots.
Constructs for subcellular localization
A GFP-fusion construct was prepared using pEGFP-N1
(Clontech). Full-length MsrA(S) was PCR-cloned into the
XhoI/EcoRI sites of pEGFP-N1, resulting in pMsrA(S)-GFP.
To create an MsrA(S)-only expression construct, a full-
length PCR fragment of MsrA(S) was cloned into the XhoI/
BsrGI sites of pEGFP-N1 that replaced the GFP coding
sequences. The construct was designated as
pMsrA(S)ΔGFP.
Fluorescence confocal microscopy
Transfections into monkey kidney CV-1 cells were per-
formed using Lipofectamine (Invitrogen). For immun-
ofluorescence staining of MsrA(S), cells were fixed as
described previously [18]. MsrA(S) proteins were stained
with polyclonal anti-rat MsrA antibodies (kindly provided
by Bertrand Friguet), followed by secondary anti-rabbit
Cy5-conjugated antibodies (Jackson ImmunoResearch
Alternative splicing of D. melanogaster MsrA and MsrB genes Figure 4
Alternative splicing of D. melanogaster MsrA and MsrB genes. (A) Genomic structures of Drosophila MsrA and MsrB 
genes. Translation initiation sites are indicated by arrows. Boxes indicate exons, which are numbered. Upper images show 
organization of the cytosolic forms of MsrA (left) and MsrB (right), respectively, and lower images of the mitochondrial forms 
of these proteins. (B) N-terminal amino acid sequences of alternatively spliced variants of MsrA and MsrB. Arrow indicates ini-
tiation of translation of cytosolic MsrB. However, this methionine is an internal residue in the mitochondrial MsrB form. Mito-
chondrial signal peptides are shown in italics.BMC Molecular Biology 2006, 7:11 http://www.biomedcentral.com/1471-2199/7/11
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Laboratories). Images were collected using a BioRad
MRC1024ES laser scanning microscope.
Western blotting
Polyclonal antibodies against rat MsrA were used to detect
MsrA proteins from mouse tissues and NIH 3T3 cells. Pro-
teins were visualized using chemiluminescent peroxidase
substrate (Sigma).
Searches for alternatively spliced forms of animal MsrA 
and MsrB
To identify alternatively spliced forms of MsrA and MsrB,
BLAST searches were carried out using various MsrA and
MsrB sequences against NCBI non-redundant, EST and
genomic databases. Only forms represented by at least 2
cDNA sequences were further considered. To determine
gene structures, cDNA sequences were aligned with corre-
sponding genomics sequences. Signal sequences were pre-
dicted with Signal P.
While this manuscript was under review, a study currently
in press reported 5'RACE (5' rapid amplification of cDNA
ends) using human retina cDNA and identified the
human MsrA(S) form [21]. This finding provides further
support for the occurrence of this form. In addition, an
additional macaque EST (CJ442767) was included in the
EST databases, which suggests the occurrence of an addi-
tional mammalian MsrA form with an alternative exon.
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